Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2761 AL 2775

Alzheimer's disease clinical trial update 2019-2021

Pleen J, Townley R.

J Neurol. 2022 Feb;269(2):1038-1051. doi: 10.1007/s00415-021-10790-5. Epub 2021 Oct 5.

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review

Jeremic D, Jiménez-Díaz L, Navarro-López JD.

Ageing Res Rev. 2021 Dec;72:101496. doi: 10.1016/j.arr.2021.101496. Epub 2021 Oct 21.

Amyloid and Tau in Alzheimer's Disease: Biomarkers or Molecular Targets for Therapy? Are We Shooting the Messenger?

Kumar A, Nemeroff CB, Cooper JJ, Widge A, Rodriguez C, Carpenter L, McDonald WM.

Am J Psychiatry. 2021 Nov;178(11):1014-1025. doi: 10.1176/appi.ajp.2021.19080873.

Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial

Lin PY, Cheng C, Satyanarayanan SK, Chiu LT, Chien YC, Chuu CP, Lan TH, Su KP.

Brain Behav Immun. 2022 Jan;99:289-298. doi: 10.1016/j.bbi.2021.10.014. Epub 2021 Oct 29.

Effects of exosomal miRNAs in the diagnosis and treatment of Alzheimer's disease

Cui GH, Zhu J, Wang YC, Wu J, Liu JR, Guo HD.

Mech Ageing Dev. 2021 Dec;200:111593. doi: 10.1016/j.mad.2021.111593. Epub 2021 Oct 28.

Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects

Tumati S, Herrmann N, Marotta G, Li A, Lanctôt KL.

Neurochem Int. 2022 Jan;152:105250. doi: 10.1016/j.neuint.2021.105250. Epub 2021 Dec 2.

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X.

Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18.

Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease: The Need for a Holistic View of the Early Pathogenesis

Merlo S, Spampinato SF, Lim D.

Biomolecules. 2021 Dec 1;11(12):1807. doi: 10.3390/biom11121807.

Natural Products as Potential Anti-Alzheimer Agents

Panda SS, Jhanji N.

Curr Med Chem. 2020;27(35):5887-5917. doi: 10.2174/0929867326666190618113613.

Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer's Disease

Jankowska A, Wesołowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2020;27(32):5351-5373. doi: 10.2174/0929867326666190620095623.

Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies

Vijayan D, Chandra R.

Curr Drug Targets. 2020;21(2):148-166. doi: 10.2174/1389450120666190806153206.

AMPK: Potential Therapeutic Target for Alzheimer's Disease

Yang L, Jiang Y, Shi L, Zhong D, Li Y, Li J, Jin R.

Curr Protein Pept Sci. 2020;21(1):66-77. doi: 10.2174/1389203720666190819142746.

Diabetic Theory in Anti-Alzheimer's Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents

Jankowska A, Wesołowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2020;27(39):6658-6681. doi: 10.2174/0929867326666191011144818.

Inhibitors of Cholinesterases in Pharmacology: the Current Trends

Pohanka M.

Mini Rev Med Chem. 2020;20(15):1532-1542. doi: 10.2174/1389557519666191018170908.

An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review

Karim N, Khan H, Khan I, Guo O, Sobarzo-Sánchez E, Rastrelli L, Kamal MA.

Med Chem. 2020;16(8):1007-1021. doi: 10.2174/1573406415666191105154407.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias